Abstract:A211the fully adjusted HR was 2.03; 95% CI (1.13-3.65) among children exposed to SSRIs alone and 4.10; 95% CI (1.35-12.41) among children exposed to combined classes of antidepressant. ConClusions: This study suggests that use of antidepressant during the 2 nd /3 rd trimester of pregnancy may increase the risk of ASD.
“…Paroxetine is commonly used in nursing homes for the treatment of depression in elderly patients . Pharmacologic differences between paroxetine and other SSRIs at the peripheral and central nervous system level might contribute to the differential risk of mortality.…”
Section: Discussionmentioning
confidence: 99%
“…The Anticholinergic Drug Scale (ADS) also classifies paroxetine as a strongly anticholinergic agent (level 2) compared with other SSRIs . Although paroxetine may be potentially inappropriate because of its strong anticholinergic properties, it is commonly used in depressed elderly patients . None of the previous studies have evaluated the risk of mortality due to paroxetine in patients with cognitive issues such as depression .…”
This study did not find any significant difference in the risk of mortality between users of paroxetine and other SSRIs among elderly nursing home patients with depression. There is a need for further evaluation of other adverse effects of paroxetine due to its anticholinergic effects in the geriatric population.
“…Paroxetine is commonly used in nursing homes for the treatment of depression in elderly patients . Pharmacologic differences between paroxetine and other SSRIs at the peripheral and central nervous system level might contribute to the differential risk of mortality.…”
Section: Discussionmentioning
confidence: 99%
“…The Anticholinergic Drug Scale (ADS) also classifies paroxetine as a strongly anticholinergic agent (level 2) compared with other SSRIs . Although paroxetine may be potentially inappropriate because of its strong anticholinergic properties, it is commonly used in depressed elderly patients . None of the previous studies have evaluated the risk of mortality due to paroxetine in patients with cognitive issues such as depression .…”
This study did not find any significant difference in the risk of mortality between users of paroxetine and other SSRIs among elderly nursing home patients with depression. There is a need for further evaluation of other adverse effects of paroxetine due to its anticholinergic effects in the geriatric population.
“…Paroxetine is commonly used in elderly nursing home patients with depression. [19][20][21] A 1-year double-blind, randomized, parallel-group, multicenter Italian study compared paroxetine and fluoxetine for cognitive functions in nondemented elderly patients with depression. This study did not find cognitive decline with the use of paroxetine and fluoxetine.…”
Section: Discussionmentioning
confidence: 99%
“…18 Although strongly anticholinergic, paroxetine is used in elderly patients with depression. [19][20][21] A review of the effects of newer antidepressants on neurocognitive function concluded that paroxetine is associated with a lower performance on neurocognitive measures such as verbal recall scores and paired-associate learning scores than other SSRIs. 22 However, none of the studies have examined the cognitive impact of individual agents, specifically paroxetine.…”
“…Although paroxetine is highly anticholinergic, it is commonly used for the treatment of depression among elderly patients (23)(24)(25). However, very little is known about its cognitive effects among elderly patients with depression.…”
Compared with use of other SSRIs, use of paroxetine was not associated with higher risk of dementia among elderly nursing home patients with depression. Future studies are needed to evaluate the impact of paroxetine on other cognition measures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.